BeOne Medicines (ONC) Cash from Operations Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 16.64% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -7.60% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 34.32% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 33.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.08% |
| Dec 31, 2025 | 49.06% |
| Sep 30, 2025 | 39.53% |
| Jun 30, 2025 | 39.14% |
| Mar 31, 2025 | 29.79% |
| Dec 31, 2024 | -16.06% |
| Sep 30, 2024 | 33.51% |
| Jun 30, 2024 | 38.96% |
| Mar 31, 2024 | -64.69% |
| Dec 31, 2023 | 12.63% |
| Sep 30, 2023 | 39.11% |
| Jun 30, 2023 | -3.78% |
| Mar 31, 2023 | -18.14% |
| Dec 31, 2022 | -6.00% |
| Sep 30, 2022 | -28.47% |
| Jun 30, 2022 | -102.00% |
| Mar 31, 2022 | -11.21% |
| Dec 31, 2021 | 38.48% |
| Sep 30, 2021 | -55.36% |
| Jun 30, 2021 | -53.09% |
| Mar 31, 2021 | 47.32% |
| Dec 31, 2020 | -77.00% |
| Sep 30, 2020 | -279.05% |
| Jun 30, 2020 | -71.77% |
| Mar 31, 2020 | -112.35% |
| Dec 31, 2019 | -117.02% |
| Sep 30, 2019 | -121.83% |
| Jun 30, 2019 | -33.78% |
| Mar 31, 2019 | -105.42% |
| Dec 31, 2018 | -126.16% |
| Sep 30, 2018 | -137.40% |
| Jun 30, 2018 | -131.10% |
| Mar 31, 2018 | -204.24% |